[HTML][HTML] Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small cell lung cancer: a phase II study
K Kubota, Y Nishiwaki, T Tamura, K Nakagawa… - Journal of Thoracic …, 2008 - Elsevier
Introduction The aim of this study was to evaluate the efficacy and safety of Erlotinib in
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small cell lung cancer: a phase II study.
K Kubota, Y Nishiwaki, T Tamura… - Journal of Thoracic …, 2008 - europepmc.org
Methods This open-label phase II trial enrolled stage III/IV NSCLC patients who had
progressive disease after at least one prior platinum-based chemotherapy regimen. Erlotinib …
progressive disease after at least one prior platinum-based chemotherapy regimen. Erlotinib …
Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer: A Phase II Study
K Kubota, Y Nishiwaki, T Tamura, K Nakagawa… - Journal of Thoracic …, 2008 - jto.org
Introduction The aim of this study was to evaluate the efficacy and safety of Erlotinib in
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
[PDF][PDF] Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer
K Kubota, Y Nishiwaki, T Tamura… - Journal of Thoracic …, 2008 - scholar.archive.org
Introduction: The aim of this study was to evaluate the efficacy and safety of Erlotinib in
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
[引用][C] Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer: A Phase II Study
K Kubota, Y Nishiwaki, T Tamura, K Nakagawa… - Journal of Thoracic …, 2008 - cir.nii.ac.jp
Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small
Cell Lung Cancer: A Phase II Study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Cell Lung Cancer: A Phase II Study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[PDF][PDF] Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer
K Kubota, Y Nishiwaki, T Tamura, K Nakagawa… - Journal of Thoracic …, 2008 - core.ac.uk
Introduction: The aim of this study was to evaluate the efficacy and safety of Erlotinib in
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small cell lung cancer: a phase II study
K Kubota, Y Nishiwaki, T Tamura… - Journal of thoracic …, 2008 - pubmed.ncbi.nlm.nih.gov
Introduction The aim of this study was to evaluate the efficacy and safety of Erlotinib in
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
Japanese patients with previously treated non-small cell lung cancer (NSCLC). Available …
[引用][C] Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small cell lung cancer: a phase II study
K KUBOTA - J Thorac Oncol, 2008 - cir.nii.ac.jp
Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small
cell lung cancer : a phase II study | CiNii Research CiNii 国立情報学研究所 学術情報 …
cell lung cancer : a phase II study | CiNii Research CiNii 国立情報学研究所 学術情報 …